Skip to the page

Data / Form D filings / Apollomics Inc.

Apollomics Inc.: Form D filing

Apollomics Inc., a biotechnology company in Foster City, CA, filed a Form D with the SEC in 2026. The latest, on August 19, 2026, reports $10 million sold of a $10 million offering to 8 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
989 Hillsdale Blvd. Suite 220, Foster City, CA, 94404
Phone
(650) 209-4055
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Cayman Islands
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1944885

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 19, 2026New notice$10,000,000$10,000,0008Aug 14, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Hung-Wen (Howard) ChenExecutive Officer, Director
Hung-Hsien YenDirector
Yi-Kuei (Alex) ChenExecutive Officer, Director
Hong-Jung (Moses) ChenDirector
Hsien-Shu (Jerry) TsaiDirector
Ya-Chi (Claudia) HuangDirector
Peter LinExecutive Officer

Other biotechnology companies in California that filed recently

Every Form D from the week of Aug 17, 2026 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Apollomics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.